A Combined Exercise Programme Involving Strengthening, Flexibility and Aerobic Exercise for Lower Back Pain

December 4, 2025 updated by: Kimberley Edwards, University of Nottingham

A Combined Exercise Programme Involving Strengthening, Flexibility and Aerobic Exercise for Lower Back Pain: a Randomised-controlled Study

This randomised controlled trial will evaluate the effectiveness of different exercise modalities for individuals with low back pain. Participants will be allocated to one of three groups: a control arm (usual exercise), a running-based intervention, or a swimming/cycling-based intervention. Outcomes related to pain and function will be measured at baseline, 8 weeks, and 12 months.

Study Overview

Status

Recruiting

Detailed Description

This study is designed to assess the impact of structured exercise interventions on pain and functional outcomes in otherwise healthy adults with low back pain. Eligible participants recruited from the community will be randomised into one of three arms: (1) control group, continuing their usual exercise activities; (2) running intervention group; or (3) swimming/cycling intervention group.

The two intervention arms will complete an 8-week combined exercise programme consisting of aerobic training (running or swimming/cycling, depending on group assignment), progressive resistance training, and prescribed flexibility exercises. The programme is structured to gradually increase in intensity over the 8-week period to enhance adherence and minimize risk of injury.

Efficacy will be evaluated using validated patient-reported outcome measures (PROMs) capturing pain intensity and functional capacity. These assessments will be administered at three time points: baseline (prior to the intervention), post-intervention (8 weeks), and long-term follow-up (12 months). This design will enable analysis of both the short-term and sustained effects of exercise modality on low back pain management.

Study Type

Interventional

Enrollment (Estimated)

88

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Notts
      • Nottingham, Notts, United Kingdom, NG7 2UH
        • Recruiting
        • University of Nottingham, Queen's Medical Centre
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Aged 18-45 years
  • Participant is willing and able to give informed consent for participation in the study
  • Suffering from chronic NSLBP (more than 3 months, localised below the costal margin and above the gluteal folds)
  • Suffers from pain or functional limitations as a result of their LBP (minimum VAS (back) score of 3/10 or ODI score of at least 5/50 or RMD score of at least 5/24 (note, unlike ODI, RMD does not describe specific cuts offs for different levels of disability)
  • Able to exercise

Exclusion Criteria:

  • Radiating pain to leg / sciatica / acute radiculopathy
  • Specific diagnosis/condition for LBP (e.g. herniated disk, degenerative disk disease, spondylolysis, spinal stenosis, spinal tumour, facet joint damage)
  • History of osteoporosis , arthritis, scoliosis, or kyphosis.
  • Current spinal infection, cancer or a current fracture (any bone).
  • History of spinal/back surgery
  • Unable to participate in physical activity and exercise
  • Pregnant or breast feeding
  • History of substance abuse
  • History of psychiatric illness (eg. depression, dementia, schizophrenia) for which currently taking medication
  • History or current neurological condition (e.g. epilepsy)
  • Not in possession or have access to adapted equipment (phone, computer, functioning WIFI)
  • Unable to understand and communicate in English
  • Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Participants continue with their usual exercise regime.
Experimental: Runner Group
Particpants follow an 8 week intervention including aerobic elements (running), a schedule of gradually intensitfing strengthening exercises and flexibility exercises.
The intervention groups undertake 8 weeks of a combined exercise programme including aerobic elements (running), a schedule of gradually intensifying strengthening exercises and flexibility exercises
Experimental: Swim/Cycle group
Particpants follow an 8 week intervention including aerobic elements (swim/cycle), a schedule of gradually intensitfing strengthening exercises and flexibility exercises.
The intervention groups undertake 8 weeks of a combined exercise programme including aerobic elements (swim/cycle), a schedule of gradually intensitfing strengthening exercises and flexibility exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS pain score
Time Frame: Baseline, 8 weeks, 12 months

VAS pain score on 100 point scale

  • Range: 0 to 100
  • Anchors: 0 = no pain, 100 = worst imaginable pain
  • Interpretation: Higher scores indicate worse pain
Baseline, 8 weeks, 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oswestry disability index
Time Frame: Baseline, 8 weeks, 12 months

Oswestry disability index (PROM questionnaire)

  • Range: 0 to 100 (expressed as a percentage)
  • Anchors: 0 = no disability, 100 = maximum disability
  • Interpretation: Higher scores indicate greater disability
Baseline, 8 weeks, 12 months
Roland Morris Disability questionnaire
Time Frame: Baseline, 8 weeks, 12 months

Roland Morris Disability questionnaire (PROM questionnaire)

  • Range: 0 to 24 (some versions extend to 0-23 or 0-25 depending on adaptation, but 0-24 is most common)
  • Anchors: 0 = no disability, 24 = maximum disability
  • Interpretation: Higher scores indicate greater disability
Baseline, 8 weeks, 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence
Time Frame: During the 8 week intervention (weekly)
Use the exercise data to assess adherence to the allocated exercise programme.
During the 8 week intervention (weekly)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kimberley Edwards, University of Nottingham

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

March 26, 2025

First Submitted That Met QC Criteria

April 3, 2025

First Posted (Actual)

April 10, 2025

Study Record Updates

Last Update Posted (Actual)

December 12, 2025

Last Update Submitted That Met QC Criteria

December 4, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

This is a small study with limited administrative support.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain, Chronic

Clinical Trials on Runner group

Subscribe